Don't miss our 🔎ePoster at #ASCO24 discussing the link between corticosteroid exposure and immune-related adverse events in patients undergoing immunotherapy. 🤓 Haydeé Verduzco Alejandro Aranda Diego Rv @HeRagosan Dhylan Soliz Alejandra Martinez-Cannon ascopubs.org/doi/10.1200/JC…

🌟Excited to share our latest review with Ilaria Colombo , diving into the evolving role of ICIs in cervical and endometrial cancer! From rationale to resistance mechanisms, it's a must-read ahead of #ESMOGynae24 next week! Check it out here: oaepublish.com/articles/cdr.2…

#CAS ESOncology #ESMOGyn2024.. relaxing evening before academics..

🌟Memorable moment with participants from the first cohort of the CAS-Gyn program at #ESMOGynae2024 in Florence! Big thanks to our amazing faculty member Ilaria Colombo . ESOncology

Esta revisión destaca la justificación para utilizar los ICI, al tiempo que delinea los mecanismos propuestos de resistencia a los ICI en el cáncer de cuello uterino y de endometrio. DOI: 10.20517/cdr.2023.120, participación del INCMNSZ , Bertha A Martínez Cannon y cols.

Seize the opportunity to spend 3-6 months at a Centre of Excellence in Europe, thanks to our Clinical Training Centres Fellowship programme for trainee oncologists! Discover more 👉 bit.ly/44w4Afb #oncology #meded

Wrapped up a successful day at the clinic and now enjoying some well-deserved team time! 🤩 Susana Banerjee Dr Nick Manning-Cork #gynaeunit

Great session on ADCs in gynaecological cancers ESMO - Eur. Oncology #ESMO24 with wonderful faculty friends and audience questions Ilaria Colombo

Stop by Andres Meraz-Brenez's poster on implementation of low-dose ICI in Mexico. Almost half of surveyed oncologists/hematologists are already using low-dose ICI, mainly due to economic reasons. However, concerns about efficacy may preclude wider implementation. INCMNSZ #ASCOQLTY24

🤩 Excited to share our new Critical Reviews in Oncology Hematology (CROH) publication on managing cervical cancer in women with HIV! Super proud of our fellows for highlighting key challenges for this vulnerable population! Evelyn Beas Sergio Contreras Salvador Jaime-Casas, MD sciencedirect.com/science/articl…

Estudio que ilustra las consideraciones especiales en el cribado, la prevención y el tratamiento del cáncer de cuello uterino en mujeres que viven con VIH. Doi: 10.1016/j.critrevonc.2024.104519, participación del INCMNSZ, Sergio Contreras y cols. #cacu #abordajecacu

Our manuscript on an online geriatric oncology educational intervention is now online in JCO Global Oncology. We designed and implemented a 12-week curriculum aimed at oncologists and geriatricians, based on Project ECHO's model. ascopubs.org/doi/10.1200/GO…

Medicine is difficult! Standing over my 46 years of clinical practice, I couldn't agree more... doi:10.1136/bmj.q2163 Thomas Dayspring Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Pam R. Taub, MD❤️💃🏻 Biljana Parapid, MD, PhD, FESC Dr Amar Puttanna 🎸 Andrew J Sauer MD Erin D. Michos, M.D. SABOURETCardiologist Claudio Tinoco Mesquita Otavio Berwanger John Kastelein 👇🏽👇🏽

Estudio internacional que describe la aceptación de las cirugías de reducción del riesgo de mujeres hispanas derivadas para una evaluación del riesgo genético de cáncer . DOI. 10.1200/GO.24.00097, participación del INCMNSZ, Yanin Chávarri y Cols.

Los invitamos a participar en el concurso por una plaza como residente en alguna de nuestras 26 especialidades para el ciclo 2026-2027. 🗣️ ¡Pasen la voz! incmnsz.mx/descargas/ense…

Check out our new study in The Lancet Reg Health-Americas: we analyzed data from 125,000+ patients with breast cancer diagnosed in São Paulo over 20 years. We found improved survival, but persistent treatment gaps and increasing delays to care. thelancet.com/journals/lanam… #bcsm #globaloncology

Join us for a special CSO webinar on June 19 where we discuss some important takeaways from #ASCO25, CSO style. Registration link: queensu.zoom.us/meeting/regist…

Phase 2 RAMP201 (ENGOTov60/GTG-UK/GOG3052)trial leading to FDA accelerated approval avumetinib and defactinib now published Journal of Clinical Oncology Verastem Oncology First approved therapy for low grade serous ovarian cancer. Thanks all. ESGO The GOG Foundation Inc. ESMO - Eur. Oncology

Such an honor to have contributed to this ASCO Global Guideline on Geriatric Assessment! We aim to support clinicians and policymakers in resource-constrained settings in assessing and addressing the geriatric needs of older patients with cancer. #gerionc